Guo, Y., Yang, H., Chen, S., Zhang, P., Li, R., Nimer, S. D., . . . Yang, F. (2018). Reduced BAP1 activity prevents ASXL1 truncation-driven myeloid malignancy in vivo. Leukemia.
Chicago Style aipamenaGuo, Ying, Hui Yang, Shi Chen, Peng Zhang, Rong Li, Stephen D. Nimer, J. William Harbour, Mingjiang Xu, and Feng-Chun Yang. "Reduced BAP1 Activity Prevents ASXL1 Truncation-driven Myeloid Malignancy in Vivo." Leukemia 2018.
MLA aipamenaGuo, Ying, et al. "Reduced BAP1 Activity Prevents ASXL1 Truncation-driven Myeloid Malignancy in Vivo." Leukemia 2018.
Kontuz: berrikusi erreferentzia hauek erabili aurretik.